PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medicago Inc., Quebec City, Quebec, Canada. wardb@medicago.com.\', \'Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. wardb@medicago.com.\', \'Medicago Inc., Quebec City, Quebec, Canada.\', \'Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.\', \'Medicago Inc., Quebec City, Quebec, Canada. landryn@medicago.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41591-021-01370-1
?:doi
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 34007070
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all